Esbjerg Hospital - University Hospital of Southern Denmark

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

No phase, Completed, 2025, 13 people, 24 Jan 2025, clinicaltrials.gov

NCT06619015

Phase 2/3, Withdrawn, 2025, 0 people, 1 Oct 2024, clinicaltrials.gov

NCT04885634

Collaborator, Phase 3, Withdrawn, 2022, 0 people, 13 May 2021, clinicaltrials.gov

NCT04842981

Collaborator, Phase 1/2, Terminated, 2021, 3 people, 13 Apr 2021, clinicaltrials.gov

NCT04702516

Collaborator, Phase 1/2, Status unknown, 2021, 64 people, 11 Jan 2021, clinicaltrials.gov

NCT03721497

Phase 4, Completed, 2020, 64 people, 26 Oct 2018, clinicaltrials.gov

NCT02192450

Collaborator, Phase 4, Completed, 2015, 149 people, 16 Jul 2014, clinicaltrials.gov

NCT01879917

Collaborator, Phase 2/3, Completed, 2014, 65 people, 18 Jun 2013, clinicaltrials.gov